Familial acquired thrombotic thrombocytopenic purpura:: ADAMTS13 inhibitory autoantibodies in identical twins

被引:45
作者
Studt, JD
Hovinga, JAK
Radonic, R
Gasparovic, V
Ivanovic, D
Merkler, M
Wirthmueller, U
Dahinden, C
Furlan, M
Lämmle, B
机构
[1] Univ Hosp Bern, Inselspital, Cent Hematol Lab, CH-3010 Bern, Switzerland
[2] Univ Zagreb, Univ Hosp, Dept Internal Med, Zagreb, Croatia
[3] Univ Hosp Bern, Inselspital, Inst Immunol, CH-3010 Bern, Switzerland
关键词
D O I
10.1182/blood-2003-11-3888
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombotic thrombocytopenic purpura (TTP) either occurs in a congenital form caused by ADAMTS13 gene mutations or it is acquired and most often due to ADAMTS13 inhibitory autoantibodies. In congenital TTP siblings are often affected, while acquired TTP occurs sporadically and familial clustering has not been described so far. We report identical twin sisters suffering from acquired TTP due to immunoglobulin G (IgG) autoantibodies inactivating ADAMTS13, suggesting an important role of hitherto unidentified genetic determinants of ADAMTS13 inhibitor formation. These cases also demonstrate that familial clustering is not sufficient for unambiguously diagnosing hereditary ADAMTS13 deficiency and congenital TTR. (C) 2004 by The American Society of Hematology
引用
收藏
页码:4195 / 4197
页数:3
相关论文
共 25 条
[1]   Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias [J].
Allford, SL ;
Hunt, BJ ;
Rose, P ;
Machin, SJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (04) :556-573
[2]   ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13 [J].
Antoine, G ;
Zimmermann, K ;
Plaimauer, B ;
Grillowitzer, M ;
Studt, JD ;
Lämmle, B ;
Scheiflinger, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (05) :821-824
[3]   Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency [J].
Assink, K ;
Schiphorst, R ;
Allford, S ;
Karpman, D ;
Etzioni, A ;
Brichard, B ;
van de Kar, N ;
Monnens, L ;
van den Heuvel, L .
KIDNEY INTERNATIONAL, 2003, 63 (06) :1995-1999
[4]   Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family [J].
Fujikawa, K ;
Suzuki, H ;
McMullen, B ;
Chung, D .
BLOOD, 2001, 98 (06) :1662-1666
[5]  
Furlan M, 1999, THROMB HAEMOSTASIS, V81, P8
[6]   Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura [J].
Furlan, M ;
Robles, R ;
Solenthaler, M ;
Lämmle, B .
BLOOD, 1998, 91 (08) :2839-2846
[7]   Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome [J].
Furlan, M ;
Robles, R ;
Galbusera, M ;
Remuzzi, G ;
Kyrle, PA ;
Brenner, B ;
Krause, M ;
Scharrer, I ;
Aumann, V ;
Mittler, U ;
Solenthaler, M ;
Lämmle, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1578-1584
[8]   Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis [J].
Furlan, M ;
Robles, R ;
Lammle, B .
BLOOD, 1996, 87 (10) :4223-4234
[9]   Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome:: the role of von Willebrand factor-cleaving protease [J].
Furlan, M ;
Lämmle, B .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (02) :437-454
[10]   Partial amino acid sequence of purified von Willebrand factor-cleaving protease [J].
Gerritsen, HE ;
Robles, R ;
Lämmle, B ;
Furlan, M .
BLOOD, 2001, 98 (06) :1654-1661